Tech Company Financing Transactions
RenovoRx Funding Round
On 5/24/2018, RenovoRx raised $10 million in funding from Boston Scientific Corporation, Acorn Campus and Astia Angel.
Transaction Overview
Company Name
Announced On
5/24/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will be used to support ongoing product development and clinical trials of RenovoCath for the treatment of patients with locally advanced pancreatic cancer.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
4546 El Camino Real 223
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Website
Email Address
Not Recorded
Overview
RenovoRx is a medical device startup headquartered in Silicon Valley, California. We develop solutions for targeted delivery of fluids, including radiopaque media and therapeutic agents, to pancreas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shaun Bagai
Chief Medical Officer
Ramtin Agah
Founder
Kamran Najmabadi
Browse more venture capital transactions:
Prev: 5/24/2018: Superpedestrian venture capital transaction
Next: 5/24/2018: Platform.sh venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs